Cardinal Health price target raised to $181 from $166 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the firm’s price target on Cardinal Health (CAH) to $181 from $166 and keeps an Overweight rating on the shares. Cardinal raised its FY25 guidance with only a few weeks left in the year, attributable to broad-based industry tailwinds, seemingly consistent with McKesson (MCK) commentary early this week, the analyst tells investors. Following an investor day event the firm describes as ” straight down the fairway,” it adds that the company’s new targets reflect the more durable favorable environment in “what we see as the ‘golden age’ of drug distribution.”